Medical Research News

RSS

European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease

Neuraxpharm Group and Minoryx Therapeutics, today announce that the European Commission (EC) has granted marketing authorization under exceptional circumstances for NEZGLYAL® (leriglitazone), an orally bioavailable, brain penetrating, selective PPAR gamma agonist, as a treatment for male cALD patients, aged 2-12 years with Gadolinium (Gd)-negative brain lesions.

26 Sep 2026

Recruitment begins for 600 future medical researchers

Through a £90 million Medical Research Council (MRC) investment, researchers will undertake PhDs and get experience in academia, healthcare and industry.

26 Sep 2026

UCLA researchers present new radiation advances at ASTRO 2026

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share new research and clinical trial findings at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, including studies on new treatment approaches for prostate, bile duct and head and neck cancers, personalized radiation therapy based on genetic risk, and advances in targeted radiation and radioligand therapy designed to improve cancer control while limiting treatment side effects.

25 Sep 2026

Toxoplasma remodels host cell surfaces to trigger invasion

At first, cholesterol and glycosylation seemed like two separate leads. As the researchers followed them, however, the pathways converged.

25 Sep 2026

AI could expand affordable tuberculosis screening in rural Philippines

In the Philippines, public healthcare remains inaccessible to many due to a variety of factors, including the high cost and limited availability of medical experts.

25 Sep 2026

Pupillary responses differ when judging glossiness and attractiveness

A research team from the Vision and Action Laboratory, Visual Perception and Cognition Laboratory, and Cognitive Neurotechnology Unit in the Department of Computer Science and Engineering at Toyohashi University of Technology, led by Associate Professor Hideki Tamura, has shown that the temporal patterns of pupillary responses differ depending on whether observers evaluate the same object images in terms of glossiness or attractiveness.

25 Sep 2026

Emerging therapies expand the treatment landscape for coronary artery disease

Announcing a new article publication for Cardiovascular Innovations and Applications. Coronary artery disease (CAD) remains the leading cause of death globally, despite the limited efficacy of current pharmacological therapies.

25 Sep 2026

Shared neural noise may not limit the brain's information capacity

Our brains internally represent the outside world through the coordinated activity of billions of neurons. A single neuron responds unreliably: even when the same stimulus is shown repeatedly, its activity varies from trial to trial.

25 Sep 2026

UC researcher receives funding to study bone complications in people with sickle cell disease

September is National Sickle Cell Awareness Month, and a University of Cincinnati College of Medicine hematology researcher has received new grant funding to study one of the disease's painful, under-recognized complications: bone damage.

25 Sep 2026

UM birding program can help stroke survivors with aphasia

On the wooded University of Montana campus, resident Cooper's hawks are helping people recover from stroke.

25 Sep 2026

Existing drug helps bladder cells destroy hidden urinary tract infections

Urinary tract infections, or UTIs, are among the most common bacterial infections, caused mostly by the uropathogenic bacterium Escherichia coli. But even after antibiotic treatment, a large number of patients experience another UTI.

25 Sep 2026

New pre-hospital blood test reduces unnecessary emergency department visits for chest pain

Researchers in The Netherlands have found that about 30% of presentations to emergency departments of patients with chest pain could be avoided if a highly sensitive troponin test is used in combination with other parameters by ambulance crews during pre-hospital triaging.

25 Sep 2026

Genomic study tracks massive chikungunya epidemic on Réunion Island

Between August 2024 and June 2025, Réunion Island experienced a massive chikungunya epidemic, with more than 54,000 confirmed cases and 43 deaths, making it the second major Chikungunya virus outbreak on the island after the 2005-2006 epidemic, which had affected about a third of the islands' population.

25 Sep 2026

Review highlights emerging treatments for glioblastoma multiforme

A new research perspective was published in Volume 13 of Oncoscience on September 17, 2026, titled "Emerging pharmacological agents for glioblastoma multiforme: An update on active clinical trials (2025–2026)."

25 Sep 2026

Cornell researchers document first case of Marfan syndrome in cats

Researchers at Cornell University have documented the first molecular characterization of Marfan syndrome in domestic cats in a paper in Scientific Reports.

25 Sep 2026

Kansas researchers secure NIH funding to fight antibiotic resistance

As antibiotic resistance makes everyday infections tougher to treat and emerging pathogens drive challenging infectious-disease outbreaks, researchers in Kansas from multiple disciplines and institutions are teaming up to target pathogens and overcome antibiotic resistance.

25 Sep 2026

Mathematical models simulate how common metals influence Alzheimer's disease

What can mathematics reveal about Alzheimer's disease? Mississippi State Associate Professor Shantia Yarahmadian is using mathematical modeling to examine how common metals may influence a protein that forms plaque associated with Alzheimer's disease-and how potential therapies could alter these processes.

25 Sep 2026